Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 08, 2022

SELL
$213.86 - $277.87 $3.99 Million - $5.19 Million
-18,667 Reduced 74.77%
6,299 $1.48 Million
Q1 2022

Apr 28, 2022

SELL
$259.82 - $298.18 $176,677 - $202,762
-680 Reduced 2.65%
24,966 $6.58 Million
Q4 2021

Feb 15, 2022

BUY
$271.6 - $314.21 $199,897 - $231,258
736 Added 2.95%
25,646 $8.06 Million
Q3 2021

Oct 26, 2021

SELL
$274.82 - $308.34 $90,965 - $102,060
-331 Reduced 1.31%
24,910 $7.01 Million
Q2 2021

Aug 11, 2021

SELL
$251.87 - $278.14 $6.26 Million - $6.92 Million
-24,866 Closed
0 $0
Q1 2021

May 14, 2021

BUY
$204.88 - $255.03 $2.48 Million - $3.08 Million
12,090 Added 94.63%
24,866 $6.34 Million
Q4 2020

Feb 02, 2021

BUY
$186.91 - $214.42 $2.39 Million - $2.74 Million
12,776 New
12,776 $2.6 Million

Others Institutions Holding LH

About LABORATORY CORP OF AMERICA HOLDINGS


  • Ticker LH
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 89,600,000
  • Market Cap $21B
  • Description
  • Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests,...
More about LH
Track This Portfolio

Track Flputnam Investment Management CO Portfolio

Follow Flputnam Investment Management CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Flputnam Investment Management CO, based on Form 13F filings with the SEC.

News

Stay updated on Flputnam Investment Management CO with notifications on news.